British Columbia Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,461
Closed -$1.1M 838
2022
Q3
$1.1M Sell
4,461
-799
-15% -$216K 0.01% 620
2022
Q2
$1.3M Sell
5,260
-1,763
-25% -$476K 0.01% 639
2022
Q1
$2.33M Sell
7,023
-930
-12% -$286K 0.01% 616
2021
Q4
$2.86M Sell
7,953
-409
-5% -$138K 0.02% 607
2021
Q3
$2.72M Sell
8,362
-2
-0% -$678 0.02% 614
2021
Q2
$2.61M Buy
8,364
+975
+13% +$299K 0.02% 648
2021
Q1
$2.35M Sell
7,389
-221
-3% -$70.7K 0.02% 611
2020
Q4
$2.47M Sell
7,610
-188
-2% -$52K 0.02% 592
2020
Q3
$2.16M Buy
7,798
+577
+8% +$166K 0.02% 568
2020
Q2
$1.74M Buy
7,221
+2,278
+46% +$457K 0.02% 589
2020
Q1
$718K Sell
4,943
-5,749
-54% -$954K 0.01% 640
2019
Q4
$1.82M Sell
10,692
-25,015
-70% -$4.64M 0.01% 697
2019
Q3
$6.35M Buy
35,707
+38
+0.1% +$8.21K 0.06% 333
2019
Q2
$9.29M Buy
35,669
+18,016
+102% +$4.78M 0.08% 252
2019
Q1
$5.04M Sell
17,653
-2,265
-11% -$753K 0.04% 424
2018
Q4
$6.47M Sell
19,918
-5,824
-23% -$2.02M 0.06% 337
2018
Q3
$11.6M Buy
25,742
+3,482
+16% +$1.37M 0.12% 186
2018
Q2
$9.11M Buy
+22,260
New +$8.06M 0.08% 282

Other funds holding ABMD

British Columbia Investment Management's ABMD Position: Q4 2022 in Review

British Columbia Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,461 shares — an estimated $1.1M sold.

British Columbia Investment Management first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $11.6M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • British Columbia Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • British Columbia Investment Management sold 4,461 Abiomed Inc shares in Q4 2022, an estimated $1.1M.
  • British Columbia Investment Management first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • British Columbia Investment Management's Abiomed Inc position peaked at $11.6M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on British Columbia Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.